# Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

> **NCT07110441** · PHASE1 · COMPLETED · sponsor: **Genfit** · enrollment: 52 (actual)

## Conditions studied

- Acute-on-Chronic Liver Failure

## Interventions

- **DRUG:** Single Dose G1090N
- **DRUG:** Multiple dosing of G1090N

## Key facts

- **NCT ID:** NCT07110441
- **Lead sponsor:** Genfit
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-26
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-03
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07110441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07110441, "Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07110441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*